AU7592998A - Modulators of tissue regeneration - Google Patents

Modulators of tissue regeneration

Info

Publication number: AU7592998A
Authority: AU; Australia
Prior art keywords: modulators; tissue regeneration; regeneration; tissue
Prior art date: 1997-05-23
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

AU75929/98A

Inventor

Richard L. Cate

Catherine A. Hession

Michele Sanicola-Nadel

Henry Wei

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Biogen Inc

Original Assignee

Biogen Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-05-23

Filing date

1998-05-22

Publication date

1998-12-11

1998-05-22 Application filed by Biogen Inc filed Critical Biogen Inc

1998-12-11 Publication of AU7592998A publication Critical patent/AU7592998A/en

Status Abandoned legal-status Critical Current

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Zoology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Pharmacology & Pharmacy (AREA)
Urology & Nephrology (AREA)
Animal Behavior & Ethology (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Veterinary Medicine (AREA)
Toxicology (AREA)
General Chemical & Material Sciences (AREA)
Gastroenterology & Hepatology (AREA)
Biochemistry (AREA)
Biophysics (AREA)
Genetics & Genomics (AREA)
Molecular Biology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Peptides Or Proteins (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)

AU75929/98A 1997-05-23 1998-05-22 Modulators of tissue regeneration Abandoned AU7592998A (en)

Applications Claiming Priority (5)

Application Number	Priority Date	Filing Date	Title
US4749197P	1997-05-23	1997-05-23
US4749097P	1997-05-23	1997-05-23
US60047490		1997-05-23
US60047491		1997-05-23
PCT/US1998/010547 WO1998053071A1 (en)	1997-05-23	1998-05-22	Modulators of tissue regeneration

Publications (1)

Publication Number	Publication Date
AU7592998A true AU7592998A (en)	1998-12-11

Family

ID=26725083

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AU75929/98A Abandoned AU7592998A (en)	1997-05-23	1998-05-22	Modulators of tissue regeneration

Country Status (5)

Country	Link
EP (1)	EP0983357A1 (en)
JP (1)	JP2002516572A (en)
AU (1)	AU7592998A (en)
CA (1)	CA2290783A1 (en)
WO (1)	WO1998053071A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU757698B2 (en) *	1998-06-01	2003-03-06	Agensys, Inc.	Novel serpentine transmembrane antigens expressed in human cancers and uses thereof

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20060052321A1 (en)	2002-04-05	2006-03-09	Raitano Arthur B	Nucleic acid and corresponding protein entitled 98P4B6 useful in treatment and detection of cancer
US20040141975A1 (en)	1998-06-01	2004-07-22	Raitano Arthur B.	Nucleic acid and corresponding protein entitled 98P4B6 useful in treatment and detection of cancer
US6833438B1 (en)	1999-06-01	2004-12-21	Agensys, Inc.	Serpentine transmembrane antigens expressed in human cancers and uses thereof
US20030149531A1 (en)	2000-12-06	2003-08-07	Hubert Rene S.	Serpentine transmembrane antigens expressed in human cancers and uses thereof
US6451969B1 (en) *	1999-01-15	2002-09-17	The Burnham Institute	Methods for inhibiting tumor metastasis, and peptides useful therfor
US20060073150A1 (en)	2001-09-06	2006-04-06	Mary Faris	Nucleic acid and corresponding protein entitled STEAP-1 useful in treatment and detection of cancer
EP1176200A3 (en)	2000-06-20	2005-01-12	Switch Biotech Aktiengesellschaft	Use of polyeptides or their encoding nucleic acids for the diagnosis or treatment of skin diseases or wound healing and their use in indentifying pharmacologically acitve substances
US6717032B2 (en)	2000-07-06	2004-04-06	Deltagen, Inc	Transgenic mice containing DEZ orphan receptor gene disruptions
WO2002003789A2 (en) *	2000-07-06	2002-01-17	Deltagen, Inc.	Transgenic mice containing targeted gpcr gene disruptions
US20060063230A1 (en)	2000-12-27	2006-03-23	Roman Naworth	Sulfatases and methods of use thereof
EP1436390A4 (en) *	2001-02-22	2005-07-20	Univ Rochester	RETINOID-INDUCIBLE PROTEINS OF VASCULAR SMOOTH MUSCLE CELLS AND USES THEREOF
US7033790B2 (en)	2001-04-03	2006-04-25	Curagen Corporation	Proteins and nucleic acids encoding same
AUPR470101A0 (en)	2001-05-02	2001-05-24	Murdoch Childrens Research Institute, The	A molecular marker
US7494646B2 (en)	2001-09-06	2009-02-24	Agensys, Inc.	Antibodies and molecules derived therefrom that bind to STEAP-1 proteins
JP2007525434A (en)	2003-03-19	2007-09-06	アブジェニックスインコーポレイテッド	Antibodies to T cells, immunoglobulin domain and mucin domain 1 (TIM-1) antigen and uses thereof.
PT1742966E (en)	2004-04-22	2014-02-05	Agensys Inc	Antibodies and molecules derived therefrom that bind to steap-1 proteins
CA2629453C (en)	2005-11-10	2018-03-06	Curagen Corporation	Method of treating ovarian and renal cancer using antibodies against t cell immunoglobulin domain and mucin domain 1 (tim-1) antigen
MX2009003938A (en)	2006-10-27	2009-04-24	Genentech Inc	Antibodies and immunoconjugates and uses therefor.
MX2010002001A (en)	2007-08-20	2010-03-11	Oncotherapy Science Inc	Cdca1 peptide and pharmaceutical agent comprising the same.
TWI526219B (en)	2008-06-19	2016-03-21	腫瘤療法科學股份有限公司	Cdca1 epitope peptides and vaccines containing the same
JP6255593B2 (en)	2012-07-10	2018-01-10	オンコセラピー・サイエンス株式会社	CD1 epitope peptide of Th1 cells and vaccine containing the same
BR112019018767A2 (en)	2017-04-03	2020-05-05	Hoffmann La Roche	antibodies, bispecific antigen binding molecule, one or more isolated polynucleotides, one or more vectors, host cell, method for producing an antibody, pharmaceutical composition, uses, method for treating a disease in an individual and invention
CN119552214B (en) *	2025-01-26	2025-04-22	杭州康源食品科技有限公司	Tetrapeptide LILP with uric acid reducing activity and application thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IL113201A0 (en) *	1994-03-31	1995-06-29	Amur Research Corp	Diagnostic agent and method for determining renal function in mammals
US5552313A (en) *	1994-11-21	1996-09-03	Kansas University	DNA encoding mouse phosphotriesterase-related protein
WO1997044460A1 (en) *	1996-05-24	1997-11-27	Biogen, Inc.	Modulators of tissue regeneration

1998
- 1998-05-22 EP EP98923700A patent/EP0983357A1/en not_active Withdrawn
- 1998-05-22 AU AU75929/98A patent/AU7592998A/en not_active Abandoned
- 1998-05-22 JP JP55070398A patent/JP2002516572A/en active Pending
- 1998-05-22 CA CA002290783A patent/CA2290783A1/en not_active Abandoned
- 1998-05-22 WO PCT/US1998/010547 patent/WO1998053071A1/en not_active Ceased

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU757698B2 (en) *	1998-06-01	2003-03-06	Agensys, Inc.	Novel serpentine transmembrane antigens expressed in human cancers and uses thereof
AU757698C (en) *	1998-06-01	2004-04-08	Agensys, Inc.	Novel serpentine transmembrane antigens expressed in human cancers and uses thereof

Also Published As

Publication number	Publication date
WO1998053071A1 (en)	1998-11-26
JP2002516572A (en)	2002-06-04
CA2290783A1 (en)	1998-11-26
EP0983357A1 (en)	2000-03-08

Publication	Publication Date	Title
HUP9902770A3 (en)	2001-09-28	Modulators of tissue regeneration
AU7592998A (en)	1998-12-11	Modulators of tissue regeneration
AU2557397A (en)	1997-10-22	Removal of tissue
EP0788804A3 (en)	1997-12-03	Medical applicator
AU2218395A (en)	1995-10-30	Bone regeneration
AU6790998A (en)	1998-10-22	Suture-passing forceps
AU1408199A (en)	1999-06-07	Patient support surfaces
AU6506698A (en)	1998-09-29	Tissue implant
AU6042298A (en)	1998-08-25	Tissue factor pathway inhibitor-3
AU1036697A (en)	1997-06-27	Surgical anchorage
AU6034096A (en)	1996-12-18	Disposable applicator
AU2315797A (en)	1997-10-22	Promotion of regeneration of organized tissues
AU6928098A (en)	1998-11-11	Optical modulator
AU2749395A (en)	1996-01-19	Medical use of bromelain
AU5055996A (en)	1996-10-24	Switched-inverter modulator
AU3145795A (en)	1996-02-22	Fibrin-cell suspension for construction of new tissue
AU4224096A (en)	1996-08-08	Use of phenylcyclohexylcarboxamides
AU6893996A (en)	1997-03-27	Use of catalysts
AU8408498A (en)	1999-04-12	Surgical handpiece
AU2870597A (en)	1998-01-29	Treatment of liquid
AU1112099A (en)	1999-05-10	Tissue removal
AU6883398A (en)	1998-10-22	Methods of treating bone loss
AU1570199A (en)	1999-07-05	Methods of lyophilizing solutions
AU2500797A (en)	1997-11-19	Methods of modulating t-cell activation
AU4931697A (en)	1998-07-16	Operation of optical modulators

Legal Events

Date	Code	Title	Description
2000-02-10	MK6	Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase